Cargando…

1072. Streamlining to Oral β-Lactam vs. Fluoroquinolone as Definitive Therapy for Enterobacteriaceae Bacteremia

BACKGROUND: Oral treatment strategies for Enterobacteriaceae bacteremia (EB) are controversial, with both β-lactams (BL) and fluoroquinolones (FQ) used in clinical practice. FQ may be preferred for their high bioavailability, but other oral antibiotics are needed due to concerns of resistance and ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fong, Karen, Dubrovskaya, Yanina, Siegfried, Justin, Papadopoulos, John, Pham, Vinh, Jen, Shin-Pung (Polly)
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254294/ http://dx.doi.org/10.1093/ofid/ofy210.909

Ejemplares similares

Clinical Outcomes of Ceftriaxone vs Penicillin G for Complicated Viridans Group Streptococci Bacteremia
por: Wo, Stephanie, et al.
Publicado: (2020)

270. Clinical Outcomes of Ceftriaxone versus Penicillin G for Complicated Viridans Group Streptococci Bacteremia
por: Wo, Stephanie, et al.
Publicado: (2020)

1441. Comparison of Cefpodoxime vs. Oral Cefuroxime for Urinary Tract Infections at a Large Academic Medical Center
por: Bao, Hongkai, et al.
Publicado: (2019)

Oral Fluoroquinolone or Trimethoprim-Sulfamethoxazole vs ß-Lactams as Step-Down Therapy for Enterobacteriaceae Bacteremia: Systematic Review and Meta-analysis
por: Punjabi, Chitra, et al.
Publicado: (2019)

Eight Years of Antimicrobial Stewardship Program (ASP) at a Large Academic Medical Center: Antibiotic Utilization, Hospital-onset Clostridium difficile infection (HO-CDI) and Resistance Trends
por: Dubrovskaya, Yanina, et al.
Publicado: (2017)

Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source
por: Sutton, Jesse D., et al.
Publicado: (2020)

2273. Outcomes of Trimethoprim/Sulfamethoxazole as Definitive Therapy for Urinary Tract Infections with Multi-Drug-Resistant Enterobacteriaceae
por: Adhi, Fatima, et al.
Publicado: (2019)

165. Comparative Effectiveness of Oral Fluoroquinolones vs. β-Lactams for the Treatment of Patients with Enterobacteriaceae Bloodstream Infections
por: Bjork, Lauren, et al.
Publicado: (2019)

210. Step-down from IV to oral therapy in patients with bacteremia due to Enterobacteriaceae: fluoroquinolones (FQ) vs. ß-lactams (BL) or trimethoprim-sulfamethoxazole (TMP-SMX)
por: Meng, Lina, et al.
Publicado: (2019)

1376. Oral Vancomycin as Secondary Prophylaxis Against Clostridioides difficile Infection in Pediatric Patients
por: Bao, Hongkai, et al.
Publicado: (2020)

Trends in Fluoroquinolone (Ciprofloxacin) Resistance in Enterobacteriaceae from Bacteremias, England and Wales, 1990–1999
por: Livermore, David M., et al.
Publicado: (2002)

222. Oral Step-Down Therapy for Uncomplicated Enterococcus Bacteremia
por: Ni, Jessica, et al.
Publicado: (2023)

Outcomes of high-dose oral beta-lactam definitive therapy compared to fluoroquinolone or trimethoprim-sulfamethoxazole oral therapy for bacteremia secondary to a urinary tract infection
por: Geyer, Abigail C., et al.
Publicado: (2023)

Multidrug-Resistant Bacteroides fragilis Bacteremia in a US Resident: An Emerging Challenge
por: Merchan, Cristian, et al.
Publicado: (2016)

271. Clinical Outcomes Treating Gram-Negative Bacteremia with Oral Beta-Lactams vs. Trimethoprim-Sulfamethoxazole or Fluoroquinolone Step-Down Therapy
por: Sinclair, Emily, et al.
Publicado: (2020)

1599. Clinical Outcomes for Patients Treated with Fluoroquinolones for Bacteremia Caused by Enterobacteriaceae Reclassified as Not Susceptible by Updated CLSI Breakpoints
por: Fleischner, Zachary, et al.
Publicado: (2020)

Short vs. (vs) Prolonged Course of Therapy for Ventilator-associated Tracheitis (VAT) Caused by Non-lactose-fermenting Gram-negative Rods (NLFGNR) in the Pediatric Intensive Care Unit (PICU)
por: Fong, Karen, et al.
Publicado: (2017)

D10.7.2: Results for GaAs photocathodes
por: Xiang, R
Publicado: (2013)

P1072: NATURAL HISTORY OF JUVENILE MYELOMONOCYTIC LEUKEMIA
por: Yang, W., et al.
Publicado: (2022)

β-Lactam Resistance and Enterobacteriaceae, United States
por: Whichard, Jean M., et al.
Publicado: (2005)

1822. Clinical Outcomes Associated with Oral Beta-Lactam Therapy versus Oral Fluoroquinolones/TMP-SMX for Uncomplicated Gram-Negative Bacteremia
por: Kaur, Satwinder S, et al.
Publicado: (2022)

959 Epidemiology and Treatment of Enterobacteriaceae Bacteremia: Combination vs Monotherapy
por: Berkowitz, Nina, et al.
Publicado: (2014)

Impact of Definitive Therapy with Beta-Lactam Monotherapy or Combination with an Aminoglycoside or a Quinolone for Pseudomonas aeruginosa Bacteremia
por: Bliziotis, Ioannis A., et al.
Publicado: (2011)

1651 Role of Metronidazole vs Vancomycin as Initial Therapy in Hospitalized Patients with Mild to Moderate Clostridium difficile Infection (CDI) with NAP1 vs non-NAP1 Disease
por: Dubrovskaya, Yanina, et al.
Publicado: (2014)

Prevalence of Beta-Lactam and Quinolone/Fluoroquinolone Resistance in Enterobacteriaceae From Dogs in France and Spain—Characterization of ESBL/pAmpC Isolates, Genes, and Conjugative Plasmids
por: Dupouy, Véronique, et al.
Publicado: (2019)

Curia y cortes en Castilla y León, 1072-1295 /
por: Procter, Evelyn Stefanos, 1897-
Publicado: (1988)

848. Low-Bioavailability vs. High-Bioavailability Oral Antibiotics for the Definitive Treatment of Enterobacteriaceae Bacteremia from Suspected Urine Source in Hospitalized Veterans
por: Sutton, Jesse D, et al.
Publicado: (2019)

Definitive Cefazolin Treatment for Community-Onset Enterobacteriaceae Bacteremia Based on the Contemporary CLSI Breakpoint: Clinical Experience of a Medical Center in Southern Taiwan
por: Lee, Ching-Chi, et al.
Publicado: (2019)

191. Appropriateness of Empiric Antibiotics for Enterobacteriaceae Bacteremia
por: Smith, Brandon J, et al.
Publicado: (2019)

1581. Impact of Colonization with Fluoroquinolone-Resistant Enterobacteriaceae on the Risk of Gram-Negative Bacteremia in Hematopoietic Stem Cell Transplant Recipients Who Receive Prophylactic Levofloxacin
por: Satlin, Michael J, et al.
Publicado: (2018)

Antimicrobial resistance in Enterobacteriaceae in Brazil: focus on β-lactams and polymyxins
por: Sampaio, Jorge Luiz Mello, et al.
Publicado: (2016)

Beta-Lactam vs. Fluoroquinolone Monotherapy for Pseudomonas aeruginosa Infection: A Systematic Review and Meta-Analysis
por: Reid, Eric, et al.
Publicado: (2021)

Emerging Health Concepts in the Probiotics Field: Streamlining the Definitions
por: Martín, Rebeca, et al.
Publicado: (2019)

Characterization of fluoroquinolone resistance and qnr diversity in Enterobacteriaceae from municipal biosolids
por: Kaplan, Ella, et al.
Publicado: (2013)

194 Antimicrobial Stewardship Evaluation of Meropenem Use at a Large Academic Medical Center
por: Dubrovskaya, Yanina, et al.
Publicado: (2014)

1072. SARS-CoV-2 Antibody Levels Associate with Neutrophil Activation
por: Warner, Seth, et al.
Publicado: (2022)

258. A Comparison of Cefprozil and Fluoroquinolones for Gram-Negative Bacteremia
por: Nolen, Rebecca C, et al.
Publicado: (2020)

Pseudomonas aeruginosa bacteremia in patients with liver cirrhosis: a comparison with bacteremia caused by Enterobacteriaceae
por: Bang, Ji Hwan, et al.
Publicado: (2013)

129. Beta-lactam vs Fluoroquinolone Monotherapy for pseudomonas Aeruginosa infection: A Systematic Review and Meta-analysis
por: Reid, Eric C, et al.
Publicado: (2020)

Diabetes does not affect outcome in patients with Enterobacteriaceae bacteremia
por: Peralta, Galo, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_cm213r6c4bdk0ev0kln0dfuhnt